Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Mankind Pharma bags CDSCO nod to start Phase 1 trials of Autoimmune drug candidate

Mankind Pharma posts over 65 percent rise in Q4 profit

Ruchika Sharma16 May 2024 4:30 PM IST

Bengaluru: Mankind Pharma, an Indian pharmaceutical company, reported a significant increase of over 65% in its fourth-quarter profit, driven by...

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

USFDA grants accelerated approval for Bristol Myers Squibb CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Ruchika Sharma16 May 2024 2:30 PM IST

Princeton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...

Alonzo Weems to retire as Executive Vice President of Enterprise Risk Management, Chief Ethics and Compliance Officer: Eli Lilly

Ruchika Sharma16 May 2024 1:15 PM IST

Indianapolis: Eli Lilly and Company has announced that Alonzo Weems, executive vice president of enterprise risk management and chief...

Lupin receives USFDA observations for two Pithampur manufacturing Units

Lupin gets ISO 14001 and ISO 45001 certification across all its Indian manufacturing sites, RnD Center, Corporate Office

Ruchika Sharma16 May 2024 12:15 PM IST

Mumbai: Global pharma major Lupin Limited has announced that all 12 of its manufacturing sites, its R&D Center and corporate office in India...

Granules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals

Granules India reports 1.6 percent fall in Q4 revenue

Ruchika Sharma15 May 2024 4:52 PM IST

Bengaluru: Granules India reported a 1.6% decrease in revenue for the fourth quarter on Wednesday, impacted by lower paracetamol sales and price...

Zydus Wellness net sales up by 9.6 percent to Rs 778 crores in Q4

Ruchika Sharma15 May 2024 3:22 PM IST

Ahmedabad: Zydus Wellness Ltd. has reported net sales of Rs 778 crores, up by 9.6% for the fourth quarter ended March 31, 2024.The company...

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

USFDA approves Roche HPV self-collection solution in US

Ruchika Sharma15 May 2024 1:05 PM IST

Basel: Roche has announced the FDA approval of its human papillomavirus (HPV) self-collection solution, one of the first available in the United...

Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million

Novo Holdings to acquire majority stake in Single Use Support

Ruchika Sharma15 May 2024 11:00 AM IST

Denmark: Novo Holdings A/S has announced that it has agreed to acquire a majority stake in Single Use Support, a fast-growing life science tools...

Shares of Indegene listed with nearly 46 percent premium

Ruchika Sharma15 May 2024 10:00 AM IST

New Delhi: Shares of Indegene Ltd, a healthcare technology company, debuted on the stock market Monday at a 45.95% premium over its issue price...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Merck discontinues Vibostolimab, Pembrolizumab coformulation arm of Phase 3 KeyVibe-010 trial in Melanoma

Ruchika Sharma14 May 2024 4:17 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the vibostolimab and pembrolizumab...

Indian Chest Society launches special booklet on cough management

Ruchika Sharma14 May 2024 1:30 PM IST

The Indian Chest Society (ICS) has unveiled a special booklet titled 'Guidelines For Cough Management in India,' focusing on the comprehensive...

AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium Cyclosilicate

AstraZeneca Pharma India, Vaayu Chest & Sleep Center collaborate to enhance respiratory care for severe asthma patients in Bengaluru

Ruchika Sharma14 May 2024 12:37 PM IST

Bengaluru: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, has partnered with Vaayu Chest & Sleep Center to elevate...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok